Last update July 24, 2014
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Main tradenames from several countries containing Demeclocycline in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 66 | % |
Molecular weight | 501 | daltons |
Protein Binding | 70 | % |
Tmax | 4 | hours |
T½ | 12 | hours |
M/P ratio | 0.7 | - |
Theoretical Dose | 0.15 | mg/Kg/d |
Relative Dose | 1.5 | % |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Although it is secreted into breast milk it has not been detected in infant’s blood because it forms unabsorbable chelate compounds with milk calcium. It is not recommended a long-term use (more than 3-4 weeks) since damage on bone growth plates, teeth discoloration, or alteration of intestinal flora may occur.
Be aware of the possibility of false negative results of bacterial cultures when the mother is on antibiotics.
Withdrawn from the market in Spain.